Women's Health
FDA Office of Women's Health (OWH)
OWH protects and promotes the health of women through policy, science, education, and outreach.
Featured
National Women's Health Week (NWHW)
This NWHW (May 10 - 16, 2026), Know Your Nutrition — learn how nutrition supports women’s health through every stage of life.
Empowering Women to Make Informed Food Choices
Get to know FDA’s recent nutrition policy updates and resources designed to help women and families make informed food choices.
Pregnancy Exposure Registries
Pregnancy exposure registries are research studies that collect health information on exposure to medical products such as medicines (drugs) and vaccines during pregnancy.
Clinical Lactation Studies
Clinical lactation studies are research studies that collect health information about the effects of medical products used while breastfeeding may have on you and/or your breast-fed baby.
Women's Health Research Roadmap
The Roadmap provides a framework for integrating women’s health science into all of FDA’s research activities.
FDA Approves Labeling Changes to MHTs
FDA has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for these drugs.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993